Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Flixoderm Eczema & Dermatitis Cream
Active Ingredient: Clobetasone butyrate 0.05%w/w
Dosage Form: Topical cream
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturers: Glaxo Wellcome Operations, Barnard Castle, County Durham, United Kingdom
UBI Asia Limited, Hsin Chu Factory, Hu Kou Hsiang, Hsin Chu Hsien, Taiwan
Product: Pyrazinamide-AFT
Active Ingredient: Pyrazinamide 500mg
Dosage Form: Tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Pharmascience Inc, Montreal, Quebec, Canada
Product: Terbinafine-DP
Active Ingredient: Terbinafine hydrochloride 281.25mg equivalent to terbinafine 250mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Actavis hf., Zetjun ztn 08, Malta
Actavis hf., Hafnarfjordur, Iceland
Dated this 6th day of October 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).